IDYA•benzinga•
IDEAYA Biosciences Expects ~$1.1B Of Cash & Equivalents As Of December 31, 2024, To Fund Operations Into At Least 2028
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga